{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:37:26Z","timestamp":1791405446792,"version":"4.3.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.radonc.2017.09.027","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T04:30:30Z","timestamp":1508214630000},"page":"258-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas"],"prefix":"10.1016","volume":"125","author":[{"given":"Debra Nana","family":"Yeboa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataniel H.","family":"Lester-Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon R.","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit S.","family":"Bindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Contessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2017.09.027_b0005","unstructured":"Radiation therapy with concomitant and adjuvant temozolomide or radiation therapy with adjuvant PCV or temozolomide alone in treating patients with anaplastic glioma (CODEL Trial). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00887146?term=NCT00887146&rank=1: ClinicalTrials.gov; October 2009. p. Trial Identifier NCT00887146."},{"key":"10.1016\/j.radonc.2017.09.027_b0010","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.86.16_supplement.PL02.005","volume":"86","author":"Jaeckle","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.radonc.2017.09.027_b0015","unstructured":"Radiation therapy with or without temozolomide in treating patients with anaplastic glioma (CATNON Trial). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00626990?term=NCT00626990&rank=1: ClinicalTrials.gov; December 2007. p. Clinical Trials Identifier NCT00626990."},{"key":"10.1016\/j.radonc.2017.09.027_b0020","doi-asserted-by":"crossref","unstructured":"Van Den Bent MJ, Erridge S, Vogelbaum MA, Nowak AK, Sanson M, Brandes AA, et al. Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p\/19q co-deletion: An Intergroup trial. ASCO Meeting Abstracts; 2016; 34: LBA2000.","DOI":"10.1200\/JCO.2016.34.15_suppl.LBA2000"},{"key":"10.1016\/j.radonc.2017.09.027_b0025","unstructured":"(NCDB) NCDB. NCDB Overview. American College of Surgeons; 20015."},{"key":"10.1016\/j.radonc.2017.09.027_b0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2307\/2532138","article-title":"Regression with frailty in survival analysis","volume":"47","author":"McGilchrist","year":"1991","journal-title":"Biometrics"},{"key":"10.1016\/j.radonc.2017.09.027_b0035","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/1475-6773.12182","article-title":"Methods for constructing and assessing propensity scores","volume":"49","author":"Garrido","year":"2014","journal-title":"Health Serv Res"},{"key":"10.1016\/j.radonc.2017.09.027_b0040","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1002\/cncr.24612","article-title":"Prognosis and patterns of care in elderly patients with glioma","volume":"115","author":"Iwamoto","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2017.09.027_b0045","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3171\/JNS\/2008\/108\/4\/0642","article-title":"Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma","volume":"108","author":"Barnholtz-Sloan","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2017.09.027_b0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00066-015-0855-x","article-title":"Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: the Mainz experience","volume":"191","author":"Mayer","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2017.09.027_b0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11060-016-2210-1","article-title":"Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy","volume":"129","author":"Shin","year":"2016","journal-title":"J Neuro-oncol"},{"key":"10.1016\/j.radonc.2017.09.027_b0060","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.2820671806","article-title":"Access to cancer prevention, detection, and treatment","volume":"67","author":"Steiner","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2017.09.027_b0065","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/neuonc\/nos081","article-title":"Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology)","volume":"14","author":"Scoccianti","year":"2012","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.radonc.2017.09.027_b0070","unstructured":"ClinicalTrials.gov. Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p\/19q Co-deleted Anaplastic Glioma or Low Grade Glioma (CODEL) NCT00887146. ClinicalTrials.gov: ClinicalTrials.gov; 2015."},{"key":"10.1016\/j.radonc.2017.09.027_b0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11060-013-1103-9","article-title":"Management and survival rates in patients with glioma in China (2004\u20132010): a retrospective study from a single-institution","volume":"113","author":"Yang","year":"2013","journal-title":"J Neuro-oncol"},{"key":"10.1016\/j.radonc.2017.09.027_b0080","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1269\/jrr.10055","article-title":"Influence of histological subtype on survival after combined therapy of surgery and radiation in WHO grade 3 glioma","volume":"51","author":"Shirai","year":"2010","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2017.09.027_b0085","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-016-2110-4","article-title":"Maximizing safe resection of low- and high-grade glioma","author":"Hervey-Jumper","year":"2016","journal-title":"J Neuro-oncol"},{"key":"10.1016\/j.radonc.2017.09.027_b0090","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3171\/2008.4.17536","article-title":"Independent association of extent of resection with survival in patients with malignant brain astrocytoma","volume":"110","author":"McGirt","year":"2009","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2017.09.027_b0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.radonc.2017.09.027_b0100","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Eckel-Passow","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2017.09.027_b0105","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Cancer Genome Atlas Research","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2017.09.027_b0110","first-page":"1359","article-title":"Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma","volume":"17","author":"Yang","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.radonc.2017.09.027_b0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijrobp.2014.10.027","article-title":"Impact of 1p\/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide","volume":"91","author":"Speirs","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.09.027_b0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2012.43.2674","article-title":"Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402","volume":"31","author":"Cairncross","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.09.027_b0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11060-016-2212-z","article-title":"Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients","volume":"129","author":"Shin","year":"2016","journal-title":"J Neuro-oncol"},{"key":"10.1016\/j.radonc.2017.09.027_b0130","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-oncology"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017325999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017325999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T20:39:25Z","timestamp":1719520765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814017325999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0167814017325999"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2017.09.027","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2017.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}